Vita 34 AG
Biobank for the cryopreservation of stem cells from umbilical cord blood and tissue.
V3V | F
Overview
Corporate Details
- ISIN(s):
- DE000A0BL849
- LEI:
- 529900OEWA4GSZEZ4P40
- Country:
- Germany
- Address:
- Perlickstr. 5, 04103 Leipzig
- Website:
- https://www.vita34.de/en/
- Industry:
- Other human health activities
Description
Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-21 07:30 |
FamiCord AG accelerates profitable growth in the third quarter of 2025 and furt…
|
English | 19.0 KB | ||
| 2025-11-21 00:00 |
Q3 statement / Q3 financial report 2025
|
English | 1.3 MB | ||
| 2025-09-16 18:53 |
FamiCord AG: Polski Bank Komorek Macierzystych sp. z o. o. is to acquire 100 % …
|
English | 6.0 KB | ||
| 2025-08-27 07:00 |
FamiCord AG significantly increases revenue and earnings in the first half of 2…
|
English | 19.8 KB | ||
| 2025-08-27 00:00 |
Half-yearly financial report 2025
|
English | 358.1 KB | ||
| 2025-08-20 13:23 | English | 3.9 KB | |||
| 2025-06-10 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
|
German | 348.2 KB | ||
| 2025-05-29 16:19 |
FamiCord AG acquires majority stake in Narodni Centrum Pupecnikove Krve and Rod…
|
English | 6.6 KB | ||
| 2025-05-28 07:00 |
FamiCord AG starts 2025 financial year with accelerated growth and increases pr…
|
English | 16.6 KB | ||
| 2025-05-28 00:00 |
Q1 statement / Q1 financial report 2025
|
English | 675.0 KB | ||
| 2025-05-19 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
|
German | 1.6 MB | ||
| 2025-05-15 15:05 |
FamiCord AG: Bekanntmachung der Einberufung zur Hauptversammlung am 25.06.2025 …
|
German | 88.4 KB | ||
| 2025-04-30 14:09 |
FamiCord AG continues growth course in 2024 after strong year-end business and …
|
English | 18.6 KB | ||
| 2025-04-30 00:00 |
Annual financial report 2024
|
English | 6.9 MB | ||
| 2025-04-23 16:18 | English | 4.4 KB |
Automate Your Workflow. Get a real-time feed of all Vita 34 AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vita 34 AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vita 34 AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-12-11 | AOC Health GmbH | Close relation | Other | None | 6,572,680.40 EUR |
| 2023-12-11 | Baran, Jakub Julian | Other | Buy | None | 99,998.80 EUR |
| 2022-09-28 | Dr. Granderath, Rat und Vermögen GmbH | Close relation | Buy | None | 21,557.28 EUR |
| 2022-06-02 | Dr. Granderath, Rat und Vermögen GmbH | Close relation | Buy | None | 33,000.00 EUR |
| 2022-06-02 | Schweppe, Thomas | Supervisory board | Other | None | N/A |
| 2021-11-18 | Lorenzen, Hans-Jochen | Supervisory board | Sell | None | 180,625.00 EUR |
| 2021-11-10 | Project Mill Gesellschaft für interdisziplinären Know-how-Transfer GmbH | Close relation | Other | None | 36,146.25 EUR |
| 2021-11-09 | Zeitfracht GmbH & Co. KGaA | Close relation | Sell | None | 35,525.00 EUR |
| 2021-11-09 | von Blücher, Dietmar | Board | Buy | None | 28,820.00 EUR |
| 2021-11-09 | von Blücher, Dietmar | Board | Buy | None | 14,400.00 EUR |
Peer Companies
